Pan, C., Duan, H., Wu, Y., Zhu, C., Yi, C., Duan, Y., . . . Huang, J. (2020). Inhibition of DNA-PK by gefitinib causes synergism between gefitinib and cisplatin in NSCLC. Int J Oncol.
استشهاد بنمط شيكاغوPan, Chi, et al. "Inhibition of DNA-PK By Gefitinib Causes Synergism between Gefitinib and Cisplatin in NSCLC." Int J Oncol 2020.
MLA استشهادPan, Chi, et al. "Inhibition of DNA-PK By Gefitinib Causes Synergism between Gefitinib and Cisplatin in NSCLC." Int J Oncol 2020.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.